Abstract
An integrated control strategy of pH, shear stress, and dissolved oxygen tension (DOT) for fermentation scale-up of the marine-derived fungus Aspergillus glaucus HB 1–19 for the production of the anti-cancer compound aspergiolide A was studied. Keeping initial pH of 6.5 and shifting pH from 6.0 to 7.0 intermittently during the production phase greatly facilitated biosynthesis of aspergiolide A in shake flask cultures. Thus, a pH-shift strategy was proposed that shifting pH to 7.0 once it went lower than 6.0 by pulsed feeding NaOH solution during the production phase in bioreactor fermentation of A. glaucus HB 1–19. As a result, aspergiolide A production in a 30-L bioreactor was increased to 37.6 mg/L, which was 48.6% higher than that in 5-L bioreactor without pH shift. Fermentation scale-up was then performed in a 500-L bioreactor on the basis of an integrated criterion of near-same impeller tip velocity of early phase, DOT levels, and pH shift. The production of aspergiolide A was successfully obtained as 32.0 mg/L, which was well maintained during the process scale-up. This work offers useful information for process development of large-scale production of marine microbial metabolites.
References
Amanullah A, Jüsten P, Davies A, Paul GC, Nienow AW, Thomas CR (2000) Agitation induced mycelial fragmentation of Aspergillus oryzae and Penicillium chrysogenum. Biochem Eng J 5:109–114
Barry E, Alvarez JA, Scully RE, Miller TL, Lipshultz SE (2007) Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother 8:1039–1058
Bhadury P, Mohammad BT, Wright PC (2006) The current status of natural products from marine fungi and their potential as anti-infective agents. J Ind Microbiol Biotechnol 33:325–337
Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR (2006) Marine natural products. Nat Prod Rep 23:26–78
Cai M, Sun X, Tao K, Zhou X, Zhang Y (2009) Statistical optimization of medium composition for aspergiolide A production by marine-derived fungus Aspergillus glaucus. J Ind Microbiol Biotechnol 36:381–389
Cai M, Zhou X, Zhou J, Niu C, Sun X, Zhang Y (2010) Efficient strategy for enhancing aspergiolide A production by citrate feedings and its effects on sexual development and growth of marine-derived fungus Aspergillus glaucus. Bioresour Technol 101:6059–6068
Cai M, Zhou X, Lu J, Fan W, Niu C, Zhou J, Sun X, Kang L, Zhang Y (2011) Enhancing aspergiolide A production from a shear-sensitive and easy-foaming marine-derived filamentous fungus Aspergillus glaucus by oxygen carrier addition and impeller combination in a bioreactor. Bioresour Technol 102:3584–3586
Du L, Zhu T, Fang Y, Liu H, Gu Q, Zhu W (2007) Aspergiolide A, a novel anthraquinone derivative with naphtho[1, 2, 3-de]chromene-2, 7-dione skeleton isolated from a marine-derived fungus Aspergillus glaucus. Tetrahedron 63:1085–1088
Elliott P (2006) Pathogenesis of cardiotoxicity induced by anthracyclines. Semin Oncol 33(3 Suppl 8):S2–S7
Herbert D, Phipps PJ, Strange RE (1971) Chemical analysis of microbiol cells. Methods Microbiol 5:209–344
Hortobagyi GN (1997) Anthracyclines in the treatment of cancer. An overview. Drugs 54:1–7
Junker BH, Hesse M, Burgess B, Masurekar P, Connors N, Seeley A (2004) Early phase process scale-up challenges for fungal and filamentous bacterial cultures. Appl Biochem Biotechnol 119:251–277
Masurekar PS (2008) Nutritional and engineering aspects of microbial process development. Prog Drug Res 65:291–328
Newman DJ, Cragg GM (2004) Advanced preclinical and clinical trials of natural products and related compounds from marine sources. Curr Med Chem 11:1693–1713
Pollard DJ, Kirschner TF, Hunt GR, Tong IT, Stieber R, Salmon PM (2007) Scale up of a viscous fungal fermentation: application of scale-up criteria with regime analysis and operating boundary conditions. Biotechnol Bioeng 96:307–317
Proksch P, Edrada RA, Ebel R (2002) Drugs from the seas: current status and microbiological implications. Appl Microbiol Biotechnol 59:125–134
Schmidt FR (2005) Optimization and scale up of industrial fermentation processes. Appl Microbiol Biotechnol 68:425–435
Smith JJ, Lilly MD, Fox RI (1990) The effect of agitation on the morphology and penicillin production of Penicillium chrysogenum. Biotechnol Bioeng 35:1011–1023
Wagner-Döbler I, Beil W, Lang S, Meiners M, Laatsch H (2002) Integrated approach to explore the potential of marine microorganisms for the production of bioactive metabolites. Adv Biochem Eng Bioechnol 74:207–238
Zhang L, An R, Wang J, Sun N, Zhang S, Hu J, Kuai J (2005) Exploring novel bioactive compounds from marine microbes. Curr Opin Microbiol 8:276–281
Acknowledgments
This work was supported by the National High Technology Research and Development Program of China (nos. 2010AA09Z402, 2011AA090702) and Shanghai Rising-Star Program (09QA1401600). We thank Prof. Qianqun Gu, Ocean University of China for supply of the strain and the aspergiolide A standard.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cai, M., Zhou, X., Lu, J. et al. An Integrated Control Strategy for the Fermentation of the Marine-Derived Fungus Aspergillus glaucus for the Production of Anti-cancer Polyketide. Mar Biotechnol 14, 665–671 (2012). https://doi.org/10.1007/s10126-012-9435-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10126-012-9435-6